Skip to main content
. 2016 Jun 11;43(1):99–107. doi: 10.1093/schbul/sbw080

Table 1.

Demographics, Medication, Family History, and Comorbidities

Psychosis n = 85 No Psychosis n = 82 P Controls n = 102
Males 30 (35%) 34 (41%) .43 56 (50%)
Females 55 (65%) 48 (59%) .43 56 (50%)
BP1 69 (81%) 16 (20%) <.00001 0
BP2 16 (19%) 66 (80%) <.00001 0
Lithium, current use 53 (62%) 34 (41%) .0085 0
Antidepressants, current use 32 (38%) 49 (60%) .0053 0
Antipsychotics, current use 33 (39%) 11 (13%) .0002 0
Antipsychotics, lifetime months use, mean ± SD 7±16 4±12 .11 0
Anticonvulsants, current use 28 (33%) 23 (28%) .51 0
Age, mean ± SD 37±13 40±13 .20 39±15
First episode, age, mean ± SD 22±9 21±11 .54 n/a
Illness duration, mean ± SD 16±10 19±14 .068 n/a
Lifetime manic episodes,a mean ± SD 3±3 3±6 .97 0
9 y education 14 (16%) 12 (15%) .83 1 (1%)
12 y education 25 (29%) 22 (27%) .73 36 (36%)
University education 46 (54%) 48 (59%) .64 61 (61%)
CGI, median (min–max) 5 (2–7) 4 (2–6) <.00001 n/a
First degree relative with bipolar disorder 16 (19%) 11 (13%) .40 0
Any relative bipolar disorder 23 (27%) 21 (26%) .86 0
First degree with schizophrenia 2 (3%) 1 (1%) 1 0
Any relative schizophrenia 6 (7%) 6 (7%) 1 0
Any suicide attempt 39 (46%) 23 (28%) .025 0
Attention deficit hyperactivity disorder 14 (16%) 31 (38%) .0028 0
Panic disorder 20 (24%) 28 (34%) .17 0
Social phobia 13 (15%) 18 (22%) .32 0
Obsessive compulsive disorder 11(13%) 11 (13%) 1 0
Generalized anxiety disorder 11 (13%) 15 (18%) .40 0
Anorexia 8 (9%) 8 (10%) 1 0
Bulimia 9 (11%) 9 (11%) 1 0
Alcohol dependence 14 (16%) 13 (16%) 1 0
Drug abuse 11 (13%) 5 (7%) .19 0
Body Mass Index, mean ± SD 26±4 24±4 .057 24±3

Note: BD1, bipolar 1 disorder; BD2, bipolar 2 disorder; CGI, clinical global impression. Fisher’s exact test, 2-tailed, was used for frequencies, Student’s 2-sided T-test for continuous variables and Mann-Whitney U-test for ordinal data.

aBipolar I subjects only.